tiprankstipranks
Trending News
More News >
Biocardia (BCDA)
:BCDA
US Market
Advertisement

BioCardia (BCDA) Technical Analysis

Compare
282 Followers

Technical Sentiment

Overall Consensus
Neutral
10Bullish
2Neutral
10Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Biocardia’s (BCDA) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Biocardia is a Sell.
Biocardia’s (BCDA) 20-Day exponential moving average is 1.97, while Biocardia’s (BCDA) share price is $2.06, making it a Buy.
Biocardia’s (BCDA) 50-Day exponential moving average is 2.04, while Biocardia’s (BCDA) share price is $2.06, making it a Buy.

BioCardia (BCDA) Pivot Points

Sep 08, 2025, 02:14 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.92
1.95
2.00
2.02
2.07
2.10
2.14
Fibonacci
1.95
1.98
2.00
2.02
2.05
2.07
2.10
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

BioCardia (BCDA) Moving Averages

Sep 08, 2025, 02:14 PM
Period
Simple
Exponential
MA5
2.02Buy
2.02Buy
MA10
1.98Buy
1.99Buy
MA20
1.90Buy
1.97Buy
MA50
2.07Sell
2.04Buy
MA100
2.16Sell
2.13Sell
MA200
2.23Sell
2.24Sell
Biocardia’s (BCDA) 10-Day exponential moving average is 1.99, while Biocardia’s (BCDA) share price is $2.06, making it a Buy.
Biocardia’s (BCDA) 100-Day exponential moving average is 2.13, while Biocardia’s (BCDA) share price is $2.06, making it a Sell.
Biocardia’s (BCDA) stock price is $2.06 and Biocardia’s (BCDA) 50-day simple moving average is 2.07, creating a Sell signal.
Biocardia’s (BCDA) stock price is $2.06 and Biocardia’s (BCDA) 100-day simple moving average is 2.16, creating a Sell signal.
Biocardia’s (BCDA) stock price is $2.06 and Biocardia’s (BCDA) 200-day simple moving average is 2.23, creating a Sell signal.

BioCardia (BCDA) Technical Indicators

Sep 08, 2025, 02:14 PM
Name
Value
Implied Action
RSI (14)
56.99
Neutral
STOCH (9,6)
91.82
Sell
STOCHRSI (14)
93.74
Sell
MACD (12,26)
>-0.01
Sell
ADX (14)
15.58
Buy
Williams %R
-10.00
Sell
CCI (14)
135.00
Sell
ATR (14)
0.10
-
Ultimate Oscillator
68.58
Neutral
ROC
7.29
Buy
Biocardia’s (BCDA) Relative Strength Index (RSI) is 56.99, creating a Neutral signal.
Biocardia’s (BCDA) Trend Strength Indicator (ADX) is 15.58, creating a Buy signal.
Biocardia’s (BCDA) Commodity Channel Index (CCI) is 135.00, creating a Sell signal.
Biocardia’s (BCDA) Price Rate of Change (ROC) is 7.29, creating a Buy signal.

FAQ

Is BCDA a Buy, Hold, or Sell?
Based on BCDA’s technical indicators, BCDA is a Hold.
    What is BCDA’s RSI (14)?
    BCDA’s RSI (14) is 56.99, which suggests BCDA is a Neutral.
      What is BCDA’s MACD?
      BCDA’s MACD is >-0.01, which suggests BCDA is a Sell.
        What is BCDA’s 5-day moving average?
        BCDA’s 5-day moving average is 2.02, which suggests BCDA is a Buy.
          What is BCDA’s 20-day moving average?
          BCDA 20-day moving average is 1.90, which suggests BCDA is a Buy.
            What is BCDA’s 50-day moving average?
            BCDA’s 50-day moving average is 2.07, which suggests BCDA is a Sell.
              What is BCDA’s 200-day moving average?
              BCDA’s 200-day moving average is 2.23, which suggests BCDA is a Sell.
                What is BCDA’s Williams % R (14)?
                BCDA’s Williams % R (14) is -10.00, which suggests BCDA is a Sell.
                  What is BCDA’s CCI (14)?
                  BCDA’s CCI (14) is 135.00, which suggests BCDA is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis